| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8235141 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 6 Pages |
Abstract
High survivin expression is a marker of tumor aggressiveness and may help to identify a subgroup of patients with T1 bladder cancer at a high risk for recurrence when treated with primary organ-sparing approaches such as TURBT and RCT.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Christian M.D., Felix von Römer, Gianni Ph.D., Oliver J. M.D., Michael M.D., Steffen F. M.D., Rolf M.D., Claus M.D., Franz Ph.D.,